Quotient Sciences
@quotientsciences.bsky.social
Offering formulation development, clinical pharmacology, clinical & commercial manufacturing services to the #pharmaceutical & #biotech industry as an integrated #CRO / #CDMO. Molecule to cure, fast. https://bit.ly/40RrMoh
In our latest #blog, our experts, Dr. Sandeep Kumar, Dr. Andrew Parker, and John McDermott, explore challenges with PROTACs and discuss how a strong CRDMO partner is essential to advancing to the clinic. Read more: bit.ly/4dUC0uf
May 27, 2026 at 8:07 PM
In our latest #blog, our experts, Dr. Sandeep Kumar, Dr. Andrew Parker, and John McDermott, explore challenges with PROTACs and discuss how a strong CRDMO partner is essential to advancing to the clinic. Read more: bit.ly/4dUC0uf
In our latest blog, Dr. Andy Lewis, Chief Scientific Officer, highlights how innovation, resilience, and speed are increasingly defining success in drug development. Read more: bit.ly/4ugCUHt
May 27, 2026 at 8:04 PM
In our latest blog, Dr. Andy Lewis, Chief Scientific Officer, highlights how innovation, resilience, and speed are increasingly defining success in drug development. Read more: bit.ly/4ugCUHt
In celebration of #NationalNursesWeek, we recognized our #nursing teams at our #clinical units in Miami and Nottingham with themed days and treats throughout the week.
Interested in joining our clinical team? Explore our open #career opportunities today: bit.ly/3vXOjTl
Interested in joining our clinical team? Explore our open #career opportunities today: bit.ly/3vXOjTl
May 12, 2026 at 3:18 PM
In celebration of #NationalNursesWeek, we recognized our #nursing teams at our #clinical units in Miami and Nottingham with themed days and treats throughout the week.
Interested in joining our clinical team? Explore our open #career opportunities today: bit.ly/3vXOjTl
Interested in joining our clinical team? Explore our open #career opportunities today: bit.ly/3vXOjTl
Don't miss Frontiers webinar happening next week featuring Dr. Andy Lewis, Chief Scientific Officer. The event will be exploring critical topics in #drugdevelopment, including the #clinical translation of #oralpeptide products and more. Register today: bit.ly/4e942D2
Welcome! You are invited to join a webinar: Frontiers in Drug Delivery | Oral Delivery of Biologics: From Mechanisms to Translation. After registering, you will receive a confirmation email about join...
Join us for the inaugural Frontiers in Drug Delivery webinar, as we delve into the oral delivery of biologics with Prof. David Brayden, Dr. Driton Vllasaliu and Dr. Andrew Lewis.
In this panel discu...
bit.ly
May 8, 2026 at 2:38 PM
Don't miss Frontiers webinar happening next week featuring Dr. Andy Lewis, Chief Scientific Officer. The event will be exploring critical topics in #drugdevelopment, including the #clinical translation of #oralpeptide products and more. Register today: bit.ly/4e942D2
This week we celebrate #NationalNursesWeek, a time to recognize the hard work of #nurses and celebrate the incredible contributions they make to our #healthcare systems. We are grateful for the amazing nurses on our teams and are proud to celebrate the critical role they play every day.
May 8, 2026 at 2:37 PM
This week we celebrate #NationalNursesWeek, a time to recognize the hard work of #nurses and celebrate the incredible contributions they make to our #healthcare systems. We are grateful for the amazing nurses on our teams and are proud to celebrate the critical role they play every day.
In this #ColleagueStory feature hear from Henry Outram, Pharmaceutical Systems Administrator at our #Nottingham site. He discusses his career and what he enjoys most about being part of the #QuotientSciences team: bit.ly/4cujvv0 #MakeYourMarkAtQS
April 28, 2026 at 9:01 PM
In this #ColleagueStory feature hear from Henry Outram, Pharmaceutical Systems Administrator at our #Nottingham site. He discusses his career and what he enjoys most about being part of the #QuotientSciences team: bit.ly/4cujvv0 #MakeYourMarkAtQS
#NationalVolunteerRecognitionDay is a time to honor the time and energy dedicated by volunteers worldwide and the immense impact they have on society. Learn about our focus on volunteer centricity, and how we enhance study outcomes through a focus on volunteer advocacy and feedback: bit.ly/4cPHwhc
April 20, 2026 at 8:03 PM
#NationalVolunteerRecognitionDay is a time to honor the time and energy dedicated by volunteers worldwide and the immense impact they have on society. Learn about our focus on volunteer centricity, and how we enhance study outcomes through a focus on volunteer advocacy and feedback: bit.ly/4cPHwhc
A recent Drug Development & Delivery article with Dr. Vanessa Zann discusses our work with Evecxia Therapeutics to support the development of EVX-101, a drug for depression and obsessive-compulsive disorder responding inadequately to first-line antidepressants: bit.ly/4tmrvVZ
April 15, 2026 at 1:38 PM
A recent Drug Development & Delivery article with Dr. Vanessa Zann discusses our work with Evecxia Therapeutics to support the development of EVX-101, a drug for depression and obsessive-compulsive disorder responding inadequately to first-line antidepressants: bit.ly/4tmrvVZ
In this article with BioPharma BoardRoom, Dr. Andy Lewis, CSO, and Dr. Christine Allen, Founder/CEO of Intrepid Labs, examine how machine learning is transforming early #drugdevelopment — reducing API demand, optimizing sparse datasets, and strengthening regulatory alignment: bit.ly/4e8uSLh
Building Trust in AI‑Enabled Formulation: Insights from Quotient Sciences and Intrepid Labs
In a BioPharma Boardroom expert opinion, Andy Lewis (Quotient Sciences) and Christine Allen (Intrepid Labs), discuss the potential of machine learning to speed up formulation development.
bit.ly
April 13, 2026 at 3:29 PM
In this article with BioPharma BoardRoom, Dr. Andy Lewis, CSO, and Dr. Christine Allen, Founder/CEO of Intrepid Labs, examine how machine learning is transforming early #drugdevelopment — reducing API demand, optimizing sparse datasets, and strengthening regulatory alignment: bit.ly/4e8uSLh
John McDermott, Vice President of Scientific Consulting, speaks with Drug Development & Delivery about how we are utilizing #AI and partnering with Intrepid Labs
to drive up to 50% faster #formulationdevelopment: bit.ly/3On9neT
to drive up to 50% faster #formulationdevelopment: bit.ly/3On9neT
April 13, 2026 at 3:27 PM
John McDermott, Vice President of Scientific Consulting, speaks with Drug Development & Delivery about how we are utilizing #AI and partnering with Intrepid Labs
to drive up to 50% faster #formulationdevelopment: bit.ly/3On9neT
to drive up to 50% faster #formulationdevelopment: bit.ly/3On9neT
Our #manufacturing scientists do important, highly skilled work every day. All with one shared goal: helping develop new medicines that make a difference to humanity.
If that sounds like your kind of environment, we'd love to hear from you! Explore our open roles: bit.ly/3vXOjTl #makeyourmarkatqs
If that sounds like your kind of environment, we'd love to hear from you! Explore our open roles: bit.ly/3vXOjTl #makeyourmarkatqs
April 13, 2026 at 3:26 PM
Our #manufacturing scientists do important, highly skilled work every day. All with one shared goal: helping develop new medicines that make a difference to humanity.
If that sounds like your kind of environment, we'd love to hear from you! Explore our open roles: bit.ly/3vXOjTl #makeyourmarkatqs
If that sounds like your kind of environment, we'd love to hear from you! Explore our open roles: bit.ly/3vXOjTl #makeyourmarkatqs
Not every drug product fits a large-scale manufacturing model: We support niche and orphan drug programs with specialized expertise and small-batch flexibility that never compromises quality. Learn more about our services: bit.ly/41WfU4A
Drug Product Development & Manufacturing Services
Pharma drug manufacturing services for small molecule and synthetic peptide drug products. Formulation development, clinical supply, and cGMP manufacturing drug product.
bit.ly
February 13, 2026 at 3:12 PM
Not every drug product fits a large-scale manufacturing model: We support niche and orphan drug programs with specialized expertise and small-batch flexibility that never compromises quality. Learn more about our services: bit.ly/41WfU4A
New reforms recently announced by the MHRA include a commitment to introduce a 14‑day initial assessment pathway for #PhaseI trials, strengthening the UK’s position as a leading destination for early‑phase clinical research. Read the full press release here: bit.ly/4kqhjbf
Patients to benefit sooner as UK boosts clinical trials attractiveness with faster assessments and agile regulation
The MHRA is now setting out the next phase of reforms for 2026, aimed at helping patients access new cutting-edge treatments more quickly and boosting the UK’s competitiveness for global clinical rese...
bit.ly
February 13, 2026 at 3:12 PM
New reforms recently announced by the MHRA include a commitment to introduce a 14‑day initial assessment pathway for #PhaseI trials, strengthening the UK’s position as a leading destination for early‑phase clinical research. Read the full press release here: bit.ly/4kqhjbf
In this article with Drug Development & Delivery, John McDermott, VP of Scientific Consulting, shares how #QuotientSciences is leveraging advanced #AI and machine learning techniques to accelerate formulation development, achieving reductions in timelines of up to 50%. Learn more: bit.ly/3On9neT
February 13, 2026 at 3:10 PM
In this article with Drug Development & Delivery, John McDermott, VP of Scientific Consulting, shares how #QuotientSciences is leveraging advanced #AI and machine learning techniques to accelerate formulation development, achieving reductions in timelines of up to 50%. Learn more: bit.ly/3On9neT
Join us for our #seminar this March in Basel! Led by John McDermott and Dr. Andrew Parker, this event will explore the critical transition of a new drug from candidate nomination through to proof-of-concept studies, highlighting strategies that drive successful early-phase programs. bit.ly/3ZCHQbP
From Bench to Bedside: Accelerating from Preclinical to POC with a Truly Integrated development partner
Join us for our seminar, "From Bench to Bedside: Accelerating from Preclinical to POC with a Truly Integrated development partner", taking place on 11th of March in Allschwil.
bit.ly
January 28, 2026 at 9:54 PM
Join us for our #seminar this March in Basel! Led by John McDermott and Dr. Andrew Parker, this event will explore the critical transition of a new drug from candidate nomination through to proof-of-concept studies, highlighting strategies that drive successful early-phase programs. bit.ly/3ZCHQbP
In our latest article with PharmTech, Dr. Asma Patel, Vice President, Global Commercial and Scientific Consulting - Drug Product, discusses the impact of patient-centric formulations on the CDMO market. Read what she has to say here: bit.ly/49MUk5w
January 28, 2026 at 9:52 PM
In our latest article with PharmTech, Dr. Asma Patel, Vice President, Global Commercial and Scientific Consulting - Drug Product, discusses the impact of patient-centric formulations on the CDMO market. Read what she has to say here: bit.ly/49MUk5w
Our dedicated volunteer management team are able to quickly find and recruit healthy volunteers and special populations. Learn more about the exploratory and regulatory-driven clinical pharmacology studies we offer: bit.ly/4o3E84Z
Early Clinical Development: Phase I Clinical Pharmacology, Regulatory & Labeling Studies
A full suite of clinical pharmacology studies.
bit.ly
January 28, 2026 at 6:58 AM
Our dedicated volunteer management team are able to quickly find and recruit healthy volunteers and special populations. Learn more about the exploratory and regulatory-driven clinical pharmacology studies we offer: bit.ly/4o3E84Z
In this article with Outsourced Pharma, Dr. Andy Lewis, Chief Scientific Officer, Matthew Paterson, Chief Strategy Officer, and Dr. Andreas Reichl, Senior Drug Development Consultant, share strategies for capturing growth in the growing market for #metabolic drugs. Read more: bit.ly/4pKsptN
January 28, 2026 at 6:57 AM
In this article with Outsourced Pharma, Dr. Andy Lewis, Chief Scientific Officer, Matthew Paterson, Chief Strategy Officer, and Dr. Andreas Reichl, Senior Drug Development Consultant, share strategies for capturing growth in the growing market for #metabolic drugs. Read more: bit.ly/4pKsptN
A new partnership with Quotient Sciences and Lindus Health will provide sponsors with enhanced patient recruitment for Phase I-IIa #clinical studies, for a seamless pathway from first-in-human (FIH) to proof-of-concept (POC) trials. Learn more: bit.ly/48LaITv
January 8, 2026 at 4:48 AM
A new partnership with Quotient Sciences and Lindus Health will provide sponsors with enhanced patient recruitment for Phase I-IIa #clinical studies, for a seamless pathway from first-in-human (FIH) to proof-of-concept (POC) trials. Learn more: bit.ly/48LaITv
We’re kicking off the new year with energy, collaboration, and big ambitions! Here’s to a fantastic start to 2026 and an exciting journey ahead.
If you’re looking for your next opportunity, explore our careers page openings here: bit.ly/3vXOjTl #Makeyourmarktqs #careers
If you’re looking for your next opportunity, explore our careers page openings here: bit.ly/3vXOjTl #Makeyourmarktqs #careers
January 8, 2026 at 4:46 AM
We’re kicking off the new year with energy, collaboration, and big ambitions! Here’s to a fantastic start to 2026 and an exciting journey ahead.
If you’re looking for your next opportunity, explore our careers page openings here: bit.ly/3vXOjTl #Makeyourmarktqs #careers
If you’re looking for your next opportunity, explore our careers page openings here: bit.ly/3vXOjTl #Makeyourmarktqs #careers
Stay in control and on course of your drug program with our #CDMO services for formulation development, clinical and commercial manufacturing. Meet our drug product team & see capabilities: bit.ly/41WfU4A
Drug Product Development & Manufacturing Services
Pharma drug manufacturing services for small molecule and synthetic peptide drug products. Formulation development, clinical supply, and cGMP manufacturing drug product.
bit.ly
January 8, 2026 at 4:44 AM
Stay in control and on course of your drug program with our #CDMO services for formulation development, clinical and commercial manufacturing. Meet our drug product team & see capabilities: bit.ly/41WfU4A
With experience spanning 35 years and more than 1,300 Phase I studies delivered, learn how #QuotientSciences can help accelerate to first-in-human and proof of concept milestones with confidence: bit.ly/3KX2X4r
Early Clinical Development
Partner with us to design and deliver your early clinical programs.
bit.ly
October 21, 2025 at 1:57 PM
With experience spanning 35 years and more than 1,300 Phase I studies delivered, learn how #QuotientSciences can help accelerate to first-in-human and proof of concept milestones with confidence: bit.ly/3KX2X4r
Dr. Andy Lewis, Chief Scientific Officer, recently contributed to PharmaSource's article, "How to Build Resilient Pharma-CDMO Partnerships in 2025". Hear Dr. Lewis' perspective on building lasting partnerships that can withstand the industry challenges of today: bit.ly/4pZM5dv
October 9, 2025 at 3:45 PM
Dr. Andy Lewis, Chief Scientific Officer, recently contributed to PharmaSource's article, "How to Build Resilient Pharma-CDMO Partnerships in 2025". Hear Dr. Lewis' perspective on building lasting partnerships that can withstand the industry challenges of today: bit.ly/4pZM5dv
We’re raising the UN Sustainable Development Goals (SDGs) flag today in recognition of our focus on turning ambition into action across our sites and teams #togetherfortheSDGs with the UN Global Compact Network UK.
Learn more about our ongoing commitment to #ESG initiatives: bit.ly/42OPC3F
Learn more about our ongoing commitment to #ESG initiatives: bit.ly/42OPC3F
September 25, 2025 at 9:39 PM
We’re raising the UN Sustainable Development Goals (SDGs) flag today in recognition of our focus on turning ambition into action across our sites and teams #togetherfortheSDGs with the UN Global Compact Network UK.
Learn more about our ongoing commitment to #ESG initiatives: bit.ly/42OPC3F
Learn more about our ongoing commitment to #ESG initiatives: bit.ly/42OPC3F
Dr. Dolly Jacob, Director of Integrated Development Services, discusses capabilities of our Miami, FL on-site compounding pharmacy to accelerate first-in-human to proof-of-concept #clinicaltrials: bit.ly/4fr4wD2
September 22, 2025 at 4:09 PM
Dr. Dolly Jacob, Director of Integrated Development Services, discusses capabilities of our Miami, FL on-site compounding pharmacy to accelerate first-in-human to proof-of-concept #clinicaltrials: bit.ly/4fr4wD2